Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Erlotinib may cause scarring hair loss.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

CS12192 effectively treats alopecia areata with better safety than current options.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

An arthritis drug helped a person with severe hair loss regrow their hair.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.